What exactly do you do for us?
Everything between "we need KOLs" and "the agreement is signed". We build the shortlist, write the outreach, send it and follow up, book the calls into your calendar and chase the CDA and agreement. You approve the list and the emails, then you show up to the calls.
How is this different from a KOL database?
A database tells you who. We get them to answer. Names are easy to find now. Replies, booked calls and signed agreements are the hard part, and that's the part we do.
Who do the KOLs hear from?
Every email is approved by you before it goes out, and we agree up front whose name and mailbox it's sent from. If you use the software, emails go from your own mailbox and replies land back next to each person's record.
Is the outreach compliant?
We write for scientific exchange and paid advisory work, never to promote a product. Your medical, legal and compliance teams can review every template first. Every email carries an opt-out, and opt-outs are honoured straight away. Fair market value and contract terms stay with your team.
How quickly can you start?
We agree the brief on the intro call. The aim is a shortlist for you to approve within a week, with the first emails going out right after.
How much does it cost?
Done-for-you is priced per project and agreed up front, so there are no surprises. The software is an annual subscription. You'll have a number for your project at the end of the intro call.
What is KOL identification and engagement?
Key opinion leaders (KOLs) are physicians and scientists whose expertise shapes how a disease is treated. KOL identification means finding the right ones for a specific need, such as an advisory board, a protocol review or a trial site. Engagement is everything after that: the first email, the follow-ups, the call, the CDA and the signed agreement. Alcor Bio does both, and most of the work is in the second part.
Do you work with medtech, diagnostics and CROs, or only pharma?
All of them. We work with pharma, biotech, medtech, diagnostics companies and CROs, and with any life sciences team that needs physicians' input. The work usually sits with medical affairs or MSL teams, but we also support clinical operations, clinical development, R&D and business development.
Which therapeutic areas and countries do you cover?
Your brief decides. We search for physicians by indication, expertise, publications, trial experience and location, so we can work in any therapeutic area where physician expertise matters, and across countries and time zones.
Can we use our own list of KOLs?
Yes. Send us your list and it sits alongside the physicians we find, in the same pipeline.
Do my colleagues need accounts?
No. A medical director or regulatory lead who only joins calls never signs in. Their calendar is synced so KOLs are only offered times that work for everyone.
What happens after a KOL signs?
That's where our job ends. We get you from the first email to the signed agreement, and the work itself carries on with your team and your tools.